Skip to main content

Table 1 Baseline demographic and clinical characteristics of laboratory confirmed enrolled malaria patients (n = 24)

From: Delayed haemolysis after treatment with intravenous artesunate in patients with severe malaria in India

 Male11 (45.83%)
 Female13 (54.16%)
 Children (1–17 years)21 (87.5%)
 Adult (18 years and above)3 (12.5%)
History of malaria and treatment taken
 History of treatment before reporting to study hospital11 (45.83%)
 History of malaria in last 6 months2 (8.33%)
Clinical findings
 Palpable splenomegaly10 (41.66%)
 Palpable hepatomegaly11 (45.83%)
Malaria diagnosis
 Positive by microscopy10 (41.7%)
 Positive by both microscopy RDT9 (37.5%)
 Positive by RDT5 (20.8%)
Hemoglobin level
 Range of Hb level on day 04.9–13.1 g/dl
Severe malaria criteria on day 0
 Severe anemia8 (33.33%)
 Impaired consciousness8 (33.33%)
 Respiratory distress- SPO2 < 92% on room air with any signs of respiratory rate > 30/min or presence of crepitations on auscultation6 (25%)
 Jaundice- plasma or serum Bilirubin > 3 mg/dl3 (12.5%)
 Shock with systolic blood pressure < 70 mm Hg in children and < 80 mm Hg in adults2 (8.33%)
 Multiple convulsions1 (4.16%)
 Renal impairment—plasma or serum creatinine > 3 mg/dl1 (4.16%)
  1. Figures in parentheses indicate percentage